Malwina Suszynska

Noskowskiego 12/14 Street
Poznan, WP 61704, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

miRNA gene mutations commonly disrupt the proper functioning of miRNA genes.

miRNA gene mutations commonly disrupt the proper functioning of miRNA genes.

Journal: Science advances
Published: February 18, 2026

BCL2 promoter region mutations are an independent marker of BCL2 level in lymphoid malignancies.

BCL2 promoter region mutations are an independent marker of BCL2 level in lymphoid malignancies.

Journal: NPJ genomic medicine
Published: January 19, 2026

Whole-miRNome sequencing: a panel for the targeted sequencing of all human miRNA genes.

Whole-miRNome sequencing: a panel for the targeted sequencing of all human miRNA genes.

Journal: Nucleic acids research
Published: March 13, 2025

CMC: Cancer miRNA Census - a list of cancer-related miRNA genes.

CMC: Cancer miRNA Census - a list of cancer-related miRNA genes.

Journal: Nucleic acids research
Published: June 26, 2023

The "Mystery Cell Population" Residing in Murine Bone Marrow - A Missing Link Between Very Small Embryonic Like Stem Cells and Hematopoietic Stem Cells?

The "Mystery Cell Population" Residing in Murine Bone Marrow - A Missing Link Between Very Small Embryonic Like Stem Cells and Hematopoietic Stem Cells?

Journal: Stem cell reviews and reports
Published: June 21, 2023

Purinergic Signaling and Its Role in Mobilization of Bone Marrow Stem Cells.

Purinergic Signaling and Its Role in Mobilization of Bone Marrow Stem Cells.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 18, 2022

Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?

Do BARD1 Mutations Confer an Elevated Risk of Prostate Cancer?

Journal: Cancers
Published: October 11, 2021

Variant Identification in BARD1, PRDM9, RCC1, and RECQL in Patients with Ovarian Cancer by Targeted Next-generation Sequencing of DNA Pools.

Variant Identification in BARD1, PRDM9, RCC1, and RECQL in Patients with Ovarian Cancer by Targeted Next-generation Sequencing of DNA Pools.

Journal: Cancer prevention research (Philadelphia, Pa.)
Published: July 13, 2021

Bone Marrow-Derived VSELs Engraft as Lung Epithelial Progenitor Cells after Bleomycin-Induced Lung Injury.

Bone Marrow-Derived VSELs Engraft as Lung Epithelial Progenitor Cells after Bleomycin-Induced Lung Injury.

Journal: Cells
Published: May 06, 2021

Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer.

Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer.

Journal: Cancers
Published: November 20, 2020

Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations.

Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations.

Journal: Genes
Published: June 30, 2020

BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases.

BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases.

Journal: Journal of ovarian research
Published: December 16, 2019
Showing 1-12 of 44

Last Updated: 09/26/2026